Capital Market Strategies’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$988K	Sell	20,310 -1,057	-5%	-$51.4K	0.69%	32
2025 Q1	$727K	Buy	21,367 +9,652	+82%	+$328K	0.49%	43
2024 Q4	$461K	Buy	+11,715	New	+$461K	0.27%	81